Thermo Fisher Scientific (TMO) stock
Last close $688.75 on 2026-11-19 (-0.58%) · Sector: Healthcare
Thermo Fisher Scientific is a large healthcare company that makes scientific instruments, lab supplies, and diagnostic tests used by labs, hospitals, and drug makers. It earns money mainly by selling these products and related services to research labs, hospitals, and pharmaceutical companies.
Thermo Fisher's sales are growing, with revenue up 8.3% and a steady operating margin of about 18%. Over the past year the stock rose 20.3% versus 9.7% for the S&P 500, so it beat the broader market. Insiders sold about $7.6 million of stock over the last 90 days and made no purchases, including a $32.8 million sale by the CEO in August. After its last four earnings releases, the stock rose the next day twice and fell the next day twice, with the largest drop at 9.2%.
Key numbers
- Market cap: $255.5B
- Revenue (last 12 months): $47.35B
- Revenue growth: +8.3%
- Operating margin: 17.9%
- P/E: 36.3
- P/S: 5.4
- Debt to equity: 0.75
- Current ratio: 1.81
Quality score
Overall 30/100 · growth 37 · profitability 41 · financial health 44 · value 0
Performance and risk
1-year return +20.3% vs S&P 500 +9.7% · volatility 30.1% (S&P 500 13.8%) · largest drop -31.4% · beta 0.68
Stock move the day after earnings
- 2026-01-29: -2.6%
- 2026-04-23: -9.2%
- 2026-07-23: +8.7%
- 2026-10-21: +1.0%
Insider trades (12 months)
Bought $0.0M · sold $137.8M
TMO stock research · TMO options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.